On May 20th a draft resolution on counterfeit medical products was submitted to the World Health Assembly by the nations of Gambia, Ghana, Nigeria, Tunisia and the United Arab Emirates. As the WHA turns to the challenges surrounding counterfeit pharmaceuticals, it is valuable to reflect on the threat counterfeit drugs pose. In particular, it is important to address the dangerous claim that “counterfeits may at times have advantages . . . (and) may even protect patients”. This argument has been presented by BUKO Pharma-Kampagne, a member of Health Action International.